Fundacion Jimenez Daaz

Madrid 28040

0 studies enrolling now · 1 studies all time

What they study most

Leukemia, Lymphocytic, Chronic, B-Cell

Studies at this site

• A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma — Completed